Bone marrow transplantation does not ameliorate the neurologic symptoms in mice deficient in hypoxanthine guanine phosphoribosyl transferase (HPRT).

Abstract

The use of bone marrow transplantation (BMT) for the treatment of genetic diseases with neurologic involvement has yielded mixed results. We have employed a mouse model of Lesch-Nyhan disease (LND) to assess the efficacy of BMT in ameliorating the neurologic manifestations of the disease. Adult HPRT-deficient mice exhibit a measurable decrease in striatal dopamine levels and a hypersensitivity to amphetamine. Marrow-ablated adult HPRT-deficient mice were transplanted with marrow from congenic HPRT-expressing mice. BMT altered neither the neurochemical nor the behavioral phenotypes in either HPRT-positive or HPRT-deficient mice. Barring any important species differences, these results suggest that BMT in its present form may not be an effective therapy for Lesch-Nyhan syndrome.

• Authors: B E Wojcik, H A Jinnah, C E Muller-Sieburg, T Friedmann
• Journal: Metabolic brain disease (Metab Brain Dis) Vol. 14 Issue 1 Pg. 57-65 (Mar 1999) ISSN: 0885-7490 [Print] United States
• PMID: 10348314 (Publication Type: Journal Article)

Chemical References

• Hypoxanthine Phosphoribosyltransferase
• Dextroamphetamine
• Dopamine

Topics

• Animals
• Behavior, Animal (drug effects, physiology)
• Bone Marrow Transplantation
• Dextroamphetamine (pharmacology)
• Disease Models, Animal
• Dopamine (metabolism)
• Female
• Hypoxanthine Phosphoribosyltransferase (deficiency)
• Lesch-Nyhan Syndrome (metabolism, physiopathology, psychology, surgery)
• Mice
• Mice, Inbred C57BL
• Nervous System Diseases (etiology)
• Prosencephalon (metabolism)